Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Persiani

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
World Journal of Surgery|June 8, 2002
Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomiesDomenico D'Ugo, Fabio Pacelli, Roberto Persiani, et al.
Journal of the American College of Surgeons|July 1, 2008
Determinants of surgical morbidity in gastric cancer treatmentRoberto Persiani, Vincenzo Antonacci, Alberto Biondi, et al.
Journal of the American College of Surgeons|October 6, 2012
The road to curative surgery in gastric cancer treatment: a different path in the elderly?Alberto Biondi, Ferdinando C M Cananzi, Roberto Persiani, et al.
Updates in Surgery|August 4, 2023
Predictors of Clostridium difficile infection after stoma reversal following TaTME surgeryFlavio Tirelli, Laura Lorenzon, Alberto Biondi, et al.
World Journal of Surgery|January 25, 2012
Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification systemRoberto Persiani, Ferdinando C M Cananzi, Alberto Biondi, et al.
BMC Surgery|June 12, 2020
D1-plus vs D2 nodal dissection in gastric cancer: a propensity score matched comparison and review of published literatureLaura Lorenzon, Rosina Giudicissi, Marco Scatizzi, et al.
Annals of Surgical Oncology|June 11, 2008
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II studyRoberto Persiani, Stefano Rausei, Carmelo Pozzo, et al.
Journal of Surgical Oncology|February 24, 2005
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomyRoberto Persiani, Domenico D'Ugo, Stefano Rausei, et al.
Journal of Cellular and Molecular Medicine|August 18, 2018
Telocytes are the physiological counterpart of inflammatory fibroid polyps and PDGFRA-mutant GISTsRiccardo Ricci, Maria Cristina Giustiniani, Marco Gessi, et al.
World Journal of Gastrointestinal Oncology|December 23, 2015
Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectivesAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
World Journal of Surgery|June 8, 2002
Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomiesDomenico D'Ugo, Fabio Pacelli, Roberto Persiani, et al.
Journal of the American College of Surgeons|July 1, 2008
Determinants of surgical morbidity in gastric cancer treatmentRoberto Persiani, Vincenzo Antonacci, Alberto Biondi, et al.
Journal of the American College of Surgeons|October 6, 2012
The road to curative surgery in gastric cancer treatment: a different path in the elderly?Alberto Biondi, Ferdinando C M Cananzi, Roberto Persiani, et al.
Updates in Surgery|August 4, 2023
Predictors of Clostridium difficile infection after stoma reversal following TaTME surgeryFlavio Tirelli, Laura Lorenzon, Alberto Biondi, et al.
World Journal of Surgery|January 25, 2012
Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification systemRoberto Persiani, Ferdinando C M Cananzi, Alberto Biondi, et al.
BMC Surgery|June 12, 2020
D1-plus vs D2 nodal dissection in gastric cancer: a propensity score matched comparison and review of published literatureLaura Lorenzon, Rosina Giudicissi, Marco Scatizzi, et al.
Annals of Surgical Oncology|June 11, 2008
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II studyRoberto Persiani, Stefano Rausei, Carmelo Pozzo, et al.
Journal of Surgical Oncology|February 24, 2005
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomyRoberto Persiani, Domenico D'Ugo, Stefano Rausei, et al.
Journal of Cellular and Molecular Medicine|August 18, 2018
Telocytes are the physiological counterpart of inflammatory fibroid polyps and PDGFRA-mutant GISTsRiccardo Ricci, Maria Cristina Giustiniani, Marco Gessi, et al.
World Journal of Gastrointestinal Oncology|December 23, 2015
Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectivesAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, et al.
Pageof 14